128 related articles for article (PubMed ID: 33989902)
1. LncRNA MAFG-AS1 affects the tumorigenesis of breast cancer cells via the miR-574-5p/SOD2 axis.
Dai J; Zhang S; Sun H; Wu Y; Yan M
Biochem Biophys Res Commun; 2021 Jun; 560():119-125. PubMed ID: 33989902
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.
Li H; Zhang GY; Pan CH; Zhang XY; Su XY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.
Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L
Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
Zhou B; Guo H; Tang J
Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.
Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y
J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MAFG-AS1 Promotes Lung Adenocarcinoma Cell Migration and Invasion by Targeting miR-3196 and Regulating SOX12 Expression.
Wu Q; Jiang J
Mol Biotechnol; 2022 Sep; 64(9):970-983. PubMed ID: 35275356
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAFG-AS1 deregulated in breast cancer affects autophagy and progression of breast cancer by interacting with miR-3612 and FKBP4 invitro.
Gao Z; Zheng G; Gong X; Hu H; Shao L; Pang Y; Wang Y; Qi A
Biochem Biophys Res Commun; 2022 Aug; 616():95-103. PubMed ID: 35653827
[TBL] [Abstract][Full Text] [Related]
14. SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis.
Zhang Y; Zhang Y; Wang S; Li Q; Cao B; Huang B; Wang T; Guo R; Liu N
Bioengineered; 2021 Dec; 12(1):2299-2310. PubMed ID: 34077295
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
Zhao W; Geng D; Li S; Chen Z; Sun M
Cancer Med; 2018 Mar; 7(3):842-855. PubMed ID: 29473328
[TBL] [Abstract][Full Text] [Related]
19. HAND2-AS1 Works as a ceRNA of miR-3118 to Suppress Proliferation and Migration in Breast Cancer by Upregulating PHLPP2.
Dong G; Wang X; Jia Y; Jia Y; Zhao W; Zhang J; Tong Z
Biomed Res Int; 2020; 2020():8124570. PubMed ID: 33015182
[TBL] [Abstract][Full Text] [Related]
20. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]